A "previvor" is someone who has never had cancer but carries a BRCA1 or BRCA2 gene variant that sharply raises their lifetime risk of developing it — a term coined in 2000 to name a genuinely new kind of medical identity. Unlike people managing a diagnosis, previvors are asked to make life-altering decisions about their bodies, fertility, and future based on probability alone. Research on this population shows a distinctive psychological pattern: not a single crisis, but a long-running negotiation with risk, uncertainty, and identity.
What Research Shows
A systematic review pooling 45 studies of cancer-unaffected BRCA1/2 carriers found that distress and anxiety typically spike immediately after a positive genetic test result, then ease over the following months. About one in five carriers showed clinically significant anxiety shortly after disclosure, and a carrier's anxiety level before testing was consistently the strongest predictor of how they coped afterward — stronger than the test result itself. Depression was measured often but was largely not found to be clinically elevated, which is a reassuring finding worth naming explicitly. Overall quality of life also appeared largely unaffected by a positive result, though younger carriers reported more difficulty feeling satisfied with their usual roles at work and at home.
Everyday Struggles
- Living with an invisible "ticking clock" feeling. Multiple studies describe previvors picturing themselves as a kind of time bomb — certain that cancer isn't a possibility but an inevitability, just a matter of when.
- Facing irreversible decisions without a diagnosis to justify them. Choosing between intensive screening and risk-reducing surgery (removing breast tissue, ovaries, or both) means weighing lifelong consequences for fertility, body image, and sexuality against a risk that may never become real.
- Carrying fear for the next generation. Many previvors describe fearing not just their own diagnosis but the possibility of passing the variant to a child, or of a child losing their mother to the disease that runs in the family.
- Misreading the body and the internet alike. A new ache, a vague symptom, or an ambiguous search result can trigger a spiral of fear — confusing clinical conversations about risk only add to that uncertainty.
- "Scanxiety" around routine monitoring. Because screening (not treatment) is the main tool for catching cancer early, previvors can experience intense dread in the days surrounding each mammogram or MRI, even though the scan itself is protective.
Fear of Cancer Occurrence: A Previvor's Distinct Experience
A recent scoping review introduced a specific term for this experience: fear of cancer occurrence (FOCO), distinguished from the fear of recurrence studied in cancer survivors because previvors are afraid of a disease that has not yet happened to them at all. The review found FOCO shows up in three recurring ways: a felt certainty that a diagnosis is only a matter of time, misinterpretation of clinical information or bodily sensations as evidence of cancer, and heightened dread around routine screening appointments. Notably, no study in the review identified previvors who knew about their elevated risk yet felt no cancer-related fear at all — suggesting FOCO may be close to a universal experience in this population, even as it remains under-researched and unmeasured by any standard clinical tool.
A Population Research Often Overlooks
Ironically, the very systematic review that mapped this field found that previvors are frequently invisible within their own research: many studies combine cancer-unaffected carriers with cancer survivors, or combine carriers with their non-carrier relatives, making it hard to isolate what previvors specifically experience. The studies that did separate them found some genuinely reassuring patterns alongside the harder ones — for example, several found that distress often eases once someone has completed a risk-reducing surgery, suggesting that reaching a decision, rather than only the decision itself, may bring a measure of relief.
Practical Tips
- Name the specific fear, not just "anxiety." Ask whether you're afraid of a future diagnosis, afraid of a decision you haven't made yet, or afraid for someone else. Fear of cancer occurrence responds differently to each of these than generic anxiety does.
- Treat genetic counseling as ongoing, not one-and-done. Because baseline anxiety shapes long-term coping more than the test result itself, revisiting counseling support (not just medical counseling) after disclosure can matter as much as the initial appointment.
- Separate screening days from the rest of your calendar. If scanxiety is intense, plan something grounding immediately after each mammogram or MRI, and avoid scheduling other high-stakes commitments around appointment days.
- Get risk information from one trusted source. Previvors describe that conflicting information from the internet, family members, and clinicians fuels fear more than the risk numbers themselves; agreeing on a single reliable source with your care team can reduce that noise.
- Connect with other previvors specifically. Because this experience differs from both average-risk worry and cancer survivorship, previvor-specific peer support groups (rather than general cancer support spaces) are often where people feel most understood.